AI regulation needs to be smarter in the UK, urges Deepmind boss June 3, 2025 Demis Hassabis, chief executive of Google Deepmind, has called on UK policymakers and business heavyweights to embrace the “smart regulation” of AI, warning that a failure to do so could prompt unintended harm, or the loss of public trust. He announced at London’s inaugural SXSW event on Monday: “AI is the most important technology humanity [...]
Google parent firm Alphabet drops pledge on using AI tech for weapons and surveillance February 5, 2025 Google’s parent company Alphabet has removed its commitment to avoiding artificial intelligence (AI) applications for weapons and surveillance from its ethical guidelines. The tech behemoth stressed the importance of collaboration between businesses and democratic governments to develop AI that “protects people, promotes global growth, and supports national security.” The revised guidelines were announced in a [...]
Court rejects appeal in data privacy class action against Google December 12, 2024 A court has rejected an appeal against a decision to throw out a data privacy class action against Google and its AI subsidiary, DeepMind
NHS: Google faces appeal over patient data deal with London’s Royal Free Hospital October 21, 2024 Tech giant Google is back in court this week as it seeks to defend off an appeal over a ruling to throw out a data privacy class action against it
Microsoft hires from Inflection AI now under microscope from competition watchdog July 16, 2024 The CMA has set an 11 September deadline to decide whether the case will progress to a phase two investigation.
Google Deepmind among nominees for ‘Nobel Prize of engineering’ June 28, 2024 AI-powered weather forecasting, innovative heat batteries and the rapid manufacturing scale-up of a Covid vaccine are the three cutting edge technologies nominated for an engineering award dubbed "the Nobel Prize of Engineering".
AI will design drugs in the next couple of years, says Google Deepmind boss February 27, 2024 The chief of Google DeepMind has said artificial intelligence (AI) could be designing drugs in clinics within the next couple of years.